This study suggests that TRMT61A-mediated tRNA-m1A58 modification could serve as a novel “translational checkpoint” for the regulation of CD4+T cell proliferation (Figure 3), offering a new RNA epigenetic regulatory strategy for the clinical modification of CD4+T cell functions to treat cancer (67). Here, CD4 is linked to cancer.